Editorial: Bioengineered gene and cell therapy for treating cardiovascular diseases

Frontiers in Bioengineering and Biotechnology

Bioengineering and Biotechnology

Kailong Li¹  Xiaoping Bao²  Xiaojun Lance Lian³  Xujie Liu⁴  Kai Wang⁵ 

[1] Beijing Key Laboratory of Protein Posttranslational Modifications and Cell Function, Department of Biochemistry and Biophysics, School of Basic Medical Sciences, Peking University Health Science Center, Beijing, China;Davdidson School of Chemical Engineering, Purdue University, West Lafayette, IN, United States;Department of Biomedical Engineering, The Huck Institutes of the Life Sciences, Pennsylvania State University, University Park, PA, United States;Department of Biology, The Huck Institutes of the Life Sciences, Pennsylvania State University, University Park, PA, United States;State Key Laboratory of Cardiovascular Disease, Fuwai Hospital, Beijing, China;State Key Laboratory of Vascular Homeostasis and Remodeling, Department of Physiology and Pathophysiology, School of Basic Medical Sciences, Peking University, Beijing, China;

关键词: maturation;    cardiomyocytes;    fibrosis;    angiogenesis;    cell therapy;   

DOI  :  10.3389/fbioe.2023.1250175

 received in 2023-06-29, accepted in 2023-07-27,  发布年份 2023

来源: Frontiers

【 授权许可】

Unknown   
Copyright © 2023 Wang, Liu, Lian, Bao and Li.